Evidence map›Paper›PMID 40855769›Full record

ArticlePsychiatry and clinical neurosciences2025

The BAsic NeuroCognitive Continuum (BANCC): Delineation of dimensional and categorical features for etiological and treatment investigations of idiopathic psychosis.

Hailey C Warren, David A Parker, Rebekah L Trotti, Victor Zeng, Shashwath Meda, Rebekka Lencer, Andreas Sprenger, S Kristian Hill, Jennifer Brown, Isaac Doss and 11 more

Abstract read
In one paragraph

Article in Psychiatry and clinical neurosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Hailey C WarrenDepartments of Psychology and Neuroscience, BioImaging Research Center, University of Georgia, Athens, Georgia, USA.ORCID https://orcid.org/0009-0003-9442-7012
David A ParkerDepartments of Psychology and Neuroscience, BioImaging Research Center, University of Georgia, Athens, Georgia, USA.
Rebekah L TrottiDepartment of Psychiatry, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Victor ZengDepartment of Psychiatry, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Shashwath MedaOlin Neuropsychiatry Research Center, Institute of Living, Hartford, Connecticut, USA.
Rebekka LencerDepartment of Psychiatry and Psychotherapy, University of Lübeck, Lübeck, Germany.
Andreas SprengerDepartment of Psychiatry and Psychotherapy, University of Lübeck, Lübeck, Germany.
S Kristian HillDepartment of Psychology, Rosalind Franklin University, Chicago, Illinois, USA.
Jennifer BrownDepartments of Psychology and Neuroscience, BioImaging Research Center, University of Georgia, Athens, Georgia, USA.
Isaac DossDepartments of Psychology and Neuroscience, BioImaging Research Center, University of Georgia, Athens, Georgia, USA.
Emily DumasDepartments of Psychology and Neuroscience, BioImaging Research Center, University of Georgia, Athens, Georgia, USA.
Elena I IvlevaDepartment of Psychiatry, UT Southwestern Medical Center, Dallas, Texas, USA.
Godfrey PearlsonOlin Neuropsychiatry Research Center, Institute of Living, Hartford, Connecticut, USA.
Matcheri KeshavanDepartment of Psychiatry, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Sarah KeedyDepartments of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, Illinois, USA.
Elliot GershonDepartments of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, Illinois, USA.
Elisabetta Del ReDepartment of Psychiatry, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Carol A TammingaDepartment of Psychiatry, UT Southwestern Medical Center, Dallas, Texas, USA.
Jennifer E McDowellDepartments of Psychology and Neuroscience, BioImaging Research Center, University of Georgia, Athens, Georgia, USA.
Robert GibbonsDepartments of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, Illinois, USA.
Brett A ClementzDepartments of Psychology and Neuroscience, BioImaging Research Center, University of Georgia, Athens, Georgia, USA.

Funding

Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
J: NRSA Training CoreTL1TR002382 · NCATS · EMORY UNIVERSITY · PI HENRY M BLUMBERG, Vasiliki Michopoulos · 2017 to 2026
$8.5M
Bipolar & Schizophrenia Consortium for Parsing Intermediate PhenotypesR01MH077851 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · PI TAMMINGA, CAROL A · 2007 to 2019
$7.8M
Bipolar & Schizophrenia Consortium for Parsing Intermediate PhenotypesR01MH077945 · NIMH · YALE UNIVERSITY · PI PEARLSON, GODFREY D · 2007 to 2019
$7.6M
Stability of Biotypes: a Longitudinal EvaluationR01MH078113 · NIMH · WAYNE STATE UNIVERSITY · PI KESHAVAN, MATCHERI S. · 2007 to 2019
$6.2M
Stability of Biotypes: a Longitudinal Evaluation (STABLE)R01MH103368 · NIMH · UNIVERSITY OF CHICAGO · PI GERSHON, ELLIOT S, KEEDY, SARAH K · 2015 to 2019
$4.5M
5/5 BIPOLAR-SCHIZOPHRENIA NETWORK FOR INTERMEDIATE PHENOTYPES (B-SNIP) - Resubmission - 1R01MH103366 · NIMH · UNIVERSITY OF GEORGIA · PI CLEMENTZ, BRETT A, GIBBONS, ROBERT D · 2015 to 2019
$3.8M
1/5 - Selective Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (Clozapine)R01MH124813 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · PI TAMMINGA, CAROL A · 2021 to 2025
$1.8M
2/5-Clozapine Response and Biomarker Correlates in Low-IEA Biotype-1R01MH124804 · NIMH · UNIVERSITY OF CHICAGO · PI GERSHON, ELLIOT S, KEEDY, SARAH K · 2021 to 2025
$1.8M
3/5 Selective Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (CLOZAPINE)R01MH124802 · NIMH · YALE UNIVERSITY · PI PEARLSON, GODFREY D · 2021 to 2025
$1.8M
5/5: Selective Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (CLOZAPINE)R01MH124803 · NIMH · UNIVERSITY OF GEORGIA · PI CLEMENTZ, BRETT A · 2021 to 2025
$1.6M
2/5 Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS)R01MH127162 · NIMH · UNIVERSITY OF CHICAGO · PI Elliot S Gershon, Sarah K Keedy · 2022 to 2026
$1.5M
John and Mary Franklin Neuroimaging Training FellowshipNCATS NIH HHS TL1 TR002382NCATS NIH HHS TL1TR002382NCATS NIH HHS UL1 TR002378NCATS NIH HHS UL1TR002378NIMH NIH HHS F32 MH135669NIMH NIH HHS F32MH135669NIMH NIH HHS MH077851NIMH NIH HHS MH077945NIMH NIH HHS MH078113NIMH NIH HHS MH096900NIMH NIH HHS MH096913NIMH NIH HHS MH096942NIMH NIH HHS MH096957NIMH NIH HHS MH103366NIMH NIH HHS MH103368NIMH NIH HHS MH124802NIMH NIH HHS MH124803NIMH NIH HHS MH124804NIMH NIH HHS MH124806NIMH NIH HHS MH124807NIMH NIH HHS MH124813NIMH NIH HHS MH126398NIMH NIH HHS MH127158NIMH NIH HHS MH127162NIMH NIH HHS MH127174NIMH NIH HHS MH127179NIMH NIH HHS R01 MH077851NIMH NIH HHS R01 MH077945NIMH NIH HHS R01 MH078113NIMH NIH HHS R01 MH096900NIMH NIH HHS R01 MH096913NIMH NIH HHS R01 MH096942NIMH NIH HHS R01 MH096957NIMH NIH HHS R01 MH103366NIMH NIH HHS R01 MH103368NIMH NIH HHS R01 MH124802NIMH NIH HHS R01 MH124803NIMH NIH HHS R01 MH124804NIMH NIH HHS R01 MH124806NIMH NIH HHS R01 MH124807NIMH NIH HHS R01 MH124813NIMH NIH HHS R01 MH127158NIMH NIH HHS R01 MH127162NIMH NIH HHS R01 MH127174NIMH NIH HHS R01 MH127179NIMH NIH HHS R21 MH126398
6 · The paper itself

Abstract

aimCognition varies across people with psychosis, including within a specific diagnosis. An important issue is identifying psychosis-specific neuro-cognitive dysfunctions. We addressed this issue by studying patterns of relationships between cognition and multiple other measures in persons with psychosis, their first-degree biological relatives, and healthy individuals (largest possible n = 2826).

methodsBrief Assessment of Cognition and Wide Range Achievement Test estimated cognitive performance. Neuroanatomical measures were FreeSurfer parcellations of 3T MRI structural brain scans. Brain functioning measures included saccades, smooth pursuit eye movements, stop signal, EEG, ERPs, resting state fMRI, plus clinical characteristics. Overall associations between 452 measures of brain structure-function and clinical characteristics (predictors) with cognitive performance (criterion) were estimated using the High Dimensional Empirical Bayes Screening algorithm.

resultsThe model yielded a common slope of predictors on cognitive performance (slope = 0.18, r = 0.33, P < 0.001). The majority (85%) of predictors fit this function, called the BAsic NeuroCognitive Continuum (BANCC). This relationship was stronger for psychosis probands (slope = 0.20, r = 0.38) than for relatives (slope = 0.09, r = 0.17) and healthy persons (slope = 0.11, r = 0.22). There were predictor-specific deviations from the common slope. Variables more strongly associated with cognitive performance (frontal-temporal-parietal lobe volumes, hippocampal regions, antisaccade performance) may tap neural architecture common to primary psychosis pathology. Variables unrelated to cognitive performance (intrinsic neural activity, volumes of lateral thalamic nuclei) distinguish specific neurophysiologically defined B-SNIP psychosis Biotypes and may capture signatures of psychosis pathophysiology. DISCUSSION: BANCC is identifiable across humans, but deviations from that common attribute identify features of brain structure-function perhaps most central and specific to psychosis-related pathophysiology.

Indexed as

BrainCognitive DysfunctionPsychotic DisordersAdolescentAdultElectroencephalographyEvoked PotentialsFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedSaccadesYoung Adultbiotypesmodelingneurobiologyneurocognitionpsychosis

Identifiers

PMID40855769
PMCPMC12580604

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.